A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

Clinical trial NCT00447980 · COMPLETED

Trial details

NCT number: NCT00447980
Sponsor: Neurotech Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2007-01-22
Primary completion: 2010-04-19
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.